CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The OSTEOforUNION project aims to develop OSTEOGROW-C, a novel biological drug that transforms a patient's blood into a personalized implant for treating bone fractures that do not heal properly. This innovative treatment uses recombinant human bone morphogenetic protein 6 to stimulate bone growth without the need for…
Bone fracture nonunion (FNU) is one of the leading unmet orthopaedic clinical needs, resulting in billions of healthcare costs annually without any drug approved by regulatory agencies for this debilitating indication.
Due to considerable shortcomings of the current best practices in treating bone FNUs, patients are facing increased risks and morbidity.
The market has available only bone substitutes and enhancers with limited clinical efficiency, highlighting an essential need for more effective…
GENERA ISTRAZIVANJA DRUSTVO S OGRANICENOM ODGOVORNOSCU ZA PROIZVODNJU BIOTEHNOLOSKIH PROIZVODA
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
